Shenqi Fuzheng Injection (参芪扶正注射液) for advanced gastric cancer: A systematic review of randomized controlled trials

Chinese Journal of Integrative Medicine

Volumn 21, Issue 1, 2015, Pages 71-79

  Li, Jiang ^a   Wang, Jian cheng ^a   Ma, Bin ^a   Gao, Wei ^b   Chen, Peng ^c   Sun, Rao ^a   Yang, Ke hu ^a  

^a LANZHOU UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

advanced gastric cancer; chemotherapy; Chinese medicine; randomized controlled trial; Shenqi Fuzheng Injection; systematic review

Indexed keywords

ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; SHENQI FUZHENG INJECTION; UNCLASSIFIED DRUG; SHENQI FUZHENG;

ADVANCED CANCER; ARTICLE; BODY WEIGHT; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER REGRESSION; CANCER RISK; HUMAN; LEUKOPENIA; META ANALYSIS; NAUSEA AND VOMITING; ORAL MUCOSITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STOMACH CANCER; SYSTEMATIC REVIEW; CANCER STAGING; INJECTION; PATHOLOGY; PUBLISHING; RISK FACTOR; STOMACH NEOPLASMS;

DRUGS, CHINESE HERBAL; HUMANS; INJECTIONS; NEOPLASM STAGING; PUBLICATION BIAS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84922076104     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-014-1768-8     Document Type: Article

References (43)

1. Wagner AD, Moehler M. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era. Curr Opin Oncol 2009;21:381–385.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
3. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006;20:633–649.
4. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33–64.
5. Sun DZ, Jiao JP, Ju DW, Ye M, Zhang X, Xu JY, et al. Tumor interstitial fluid and gastric cancer metastasis: an experimental study to verify the hypothesis of “tumor-phlegm micro-environment”. Chin J Integr Med 2012;18:350–358.
6. Park JW, Yoon J, Cho CK, Lee YW, Yoo HS. Survival analysis of stage IV metastatic gastric cancer patients treated with HangAm-Plus. Chin J Integr Med 2014;20:49–55.
7. Roy A, Cunningham D, Hawkins R, Sörbye H, Adenis A, Barcelo JR, et al. Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophagogastric cancer: a randomised phase II study. Br J Cancer 2012;107:435–441.
8. Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako M, et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993;11:1441–1447.
9. Yeh JM, Hur C, Kuntz KM, Ezzati M, Goldie SJ. Costeffectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer 2010;116:2941–2953.
10. Acupuncture stimulated healing. http://www.koreatimes.co.kr/www/news/art/2009/10/153_38654.html
11. Dharmananda S. Kampo medicine: the practice of Chinese herbal medicine in Japan. Portland, OR: Institute for Traditional Medicine; 2001.
12. Chen Z, Gu K, Zheng Y, Zheng W, Lu W, Shu XO. The use of complementary and alternative medicine among Chinese women with breast cancer. J Altern Complement Med 2008;14:1049–1055.
13. McCulloch M, See C, Shu XJ, Broffman M, Kramer A, Fan WY, et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clin Oncol 2006;24:419–430.
14. Pan CX, Morrison RS, Ness J, Fugh-Berman A, Leipzig RM. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. J Pain Symptom Manage 2000;20:374–387.
15. Lu Y, Lu YX. Clinical application and pharmacology function of Shenqi Fuzheng Injection. Lishizhen Med Mater Med Res (Chin) 2006;17:2083–2085.
16. Sheng S, Song M. The component analysis of Shengqi Fuzheng Injection. J China Prescript Drug (Chin) 2004;8:47–49.
17. Pan L. Practical road of “the numeral turn Chinese herbal medicine” for Shenqi Fuzheng Injection. J China Prescript Drug (Chin) 2009;1:37–39.
18. Zhong ZH. Dictate history: a national new medicine that come from experiential prescription. J China Prescript Drug (Chin) 2009;1:33–36.
19. Hollen PJ, Gralla RJ, Kris MG, Cox C, Belani CP, Grunberg SM, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Cancer 1994;73:2087–2098.
20. Zhou HJ, So JB, Yong WP, Luo N, Zhu F, Naidoo N, et al. Validation of the functional assessment of cancer therapy—gastric module for the Chinese population. Health Qual Life Outcomes 2012;10:145.
21. National Cancer Institute. Common terminology criteria for adverse events and common toxicity criteria. Version 4.0. Bethesda: NCI; 2010. http://ctep.cancer.gov/protocolDevelopment/electronicapplications/ctc.htm#ctc_40.
22. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12.
23. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42–46.
24. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924–926.
25. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in metaanalyses? Lancet 1998;352:609–613.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–188.
27. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–560.
28. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
29. Fang XY. Observation of efficacy of Shenqi Fuzheng Injection combined with FOLFOX4 chemotherapy in treatment of advanced gastric cancer. Chin J Pract Med (Chin) 2010;37:23–24.
30. Jia JW, Liu YQ. Effect of Shenqi Fuzheng Injection combined with FOLFOX4 regimen in the treatment of advanced gastric cancer. Pract J Cancer (Chin) 2009;24:273–275.
31. Li ZY, Huang QH, Xu HS, Ruan XF. The efficacy of Shenqi Fuzheng Injection combined with chemotherapy in gastric cancer. J Liaoning Univ Tradit Chin Med (Chin) 2006;8:26–27.
32. Liu H, Han D. Effects of Shenqi Fuzheng Injection on the immunolologic function and clinic efficacy in the elderly patients with advanced gastric cancer. Chin J Clin Pharmacol (Chin) 2011;27:177–183.
33. Luo PF. The efficacy of Shenqi Fuzheng Injection combination chemotherapy for advanced gastric cancer. Modern Med Health (Chin) 2011;27:1170–1171.
34. Wan LX, Wang Y. Shenqi Fuzheng Injectiong combined with FOLFOX4 for advanced gastric cancer. J Med Forum (Chin) 2006;27:96–97.
35. Wang JF. Shenqi Fuzheng Injection combined chemoradiotherapy treatment of locally advanced gastric cancer. Chin Med Sci Technol (Chin) 2010;17:537–538.
36. Wang M, Lin HJ. Efficacy observation of Shenqi Fuzheng Injection combined with FOLFOX4 chemotherapy in treatment of advanced gastric cancer. Drugs Clin (Chin) 2011;18:89–90.
37. Wang YS, Shi ZX, Guo YH. Shenqi Fuzheng Injection combination chemotherapy for elderly patients with advanced gastric cancer. Med J West Chin (Chin) 2011;23:1958–1959.
38. Xiong W. The efficacy Shenqi Fuzheng Injection with DCF chemotherapy in advanced gastric cancer. Guangming Chin Med (Chin) 2010;25:635–636.
39. Yue CL. Clinical observation of chemotherapy combined with Shenqi Fuzheng Injection treating gastric cancer. Chin New Med (Chin) 2003;4:1063–1064.
40. Zhao JM, Wu AZ, Shi LR, Yang XX, Li JH, Wu CP. Clinical observation on treatment of advanced gastric cancer by combined use of Shenqi Fuzheng Injection, docetaxel, flurouracil and calcium folinate. Chin J Integr Tradit West Med (Chin) 2007;27:736–738.
41. Zhou KX, Wang JH, Liu BK, Zhou CY, Xin M, Zhi JL, et al. Clinical study on effect of Shenqi Fuzheng Injection combined with chemotherapy in treating gastric cancer. Chin J Integr Tradit West Med (Chin) 1999;19:11–13.
42. Shao BM, Xu W, Dai H, Tu P, Li Z, Gao XM. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun 2004;320:1103–1111.
43. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359:614–618